Search results
Results From The WOW.Com Content Network
Pap test. The Papanicolaou test (abbreviated as Pap test, also known as Pap smear (AE), [1] cervical smear (BE), cervical screening (BE), [2] or smear test (BE)) is a method of cervical screening used to detect potentially precancerous and cancerous processes in the cervix (opening of the uterus or womb) or, more rarely, anus (in both men and ...
Cervical cancer screening recommendations have not changed for females who receive HPV vaccine. It remains a recommendation that women continue cervical screening, such as Pap smear testing, even after receiving the vaccine, since it does not prevent all types of cervical cancer. [159] [161] Both men and women are carriers of HPV. [162]
The preferred screening for women aged 30–65 is "co-testing", which includes a combination of cervical cytology screening and HPV testing, every 5 years. [11] However, it is acceptable to screen this age group with a Pap smear alone every 3 years or with an FDA-approved primary high risk HPV test every 5 years. [11]
people of reproductive age who have received an abnormal PAP smear within the past 36 months. Every 5 years, people ages 30 to 65 years with no symptoms of HPV can get HPV screening during their ...
Medicare covers HPV testing starting from the age of 30 years. Screening coverage through Part B lasts until the age of 65 years. Part B covers tests once every 5 years if a person does not have ...
Papanicolaou stain (also Papanicolaou's stain and Pap stain) is a multichromatic (multicolored) cytological staining technique developed by George Papanicolaou in 1942. [ 1 ] [ 2 ] [ 3 ] The Papanicolaou stain is one of the most widely used stains in cytology , [ 1 ] where it is used to aid pathologists in making a diagnosis.
The Pap test can be used as a screening test, but produces a false negative in up to 50% of cases of cervical cancer. [56] [57] Other concerns is the cost of doing Pap tests, which make them unaffordable in many areas of the world. [58] Confirmation of the diagnosis of cervical cancer or precancer requires a biopsy of the cervix.
The two screening methods available are the Pap smear and testing for HPV. CIN is usually discovered by a screening test, the Pap smear. The purpose of this test is to detect potentially precancerous changes through random sampling of the transformation zone. Pap smear results may be reported using the Bethesda system (see above).